Just eight months after Morocco’s first fintech listing drew record demand, the Casablanca Stock Exchange has hosted another blockbuster initial public offering, underscoring a remarkable revival in North Africa’s largest equity market.
T2S Group Holding, a Moroccan integrated medical technology group, began trading on Monday after its IPO was oversubscribed 43.75 times, drawing more than 48.12 billion dirhams ($5.14bn) in orders from over 111,000 investors. The strong demand left retail and institutional subscribers with an average allocation rate of just 2.29 per cent.
The 1.1 billion dirham ($117m) offering — comprising a 350 million dirham capital increase and a 750 million dirham secondary sale of existing shares — is the first listing of 2026 on the Casablanca bourse. It follows the December 2025 debut of Cash Plus, a Moroccan fintech that raised $82.5m at a $550m valuation and was oversubscribed 64 times.
“This IPO is very good news for all capital market participants,” Nasser Seddiqi, chief executive of the Casablanca Stock Exchange, told the listing ceremony. “More than 110,000 investors wished to become shareholders of T2S, while demand exceeded 43 times the number of shares offered”.
The back-to-back tech listings mark an acceleration for a bourse that until 2025 had not seen a major technology IPO in years. Cash Plus became the first fintech to list on the exchange, while T2S is the first MedTech group to go public since healthcare company Vicenne’s oversubscribed IPO in July 2025.
Founded in 1992 by Abderraouf Sordo, T2S supplies medical equipment, diagnostic systems, radiopharmaceutical products and hospital software. The group operates through four subsidiaries, employs more than 400 people and partners with over 40 international MedTech companies including GE HealthCare, BioMérieux, Accuray and Boston Scientific.
The company reported revenue of 1.76 billion dirhams ($188m) and net profit of 211 million dirhams ($22.5m) in 2025. It expects revenue to grow to 4.17 billion dirhams ($445m) by 2030, with net profit projected to reach 607 million dirhams ($64.8m).
IPO proceeds will fund a second cyclotron facility in Fez, the rollout of diagnostic equipment, upgrades to information technology systems and cybersecurity investments. The company is also pursuing expansion in sub-Saharan Africa, with new oncology projects planned in Côte d’Ivoire, Mali and Senegal. T2S already operates in more than 20 African countries.
The offering comprised 4.93 million shares priced at 223 dirhams each, valuing the business at approximately 4.86 billion dirhams ($519m). After the listing, the free float will represent about 22.6 per cent of the company, while existing controlling shareholders will remain subject to lock-up agreements.
Retail Investors Lead the Charge
One of the most striking features of the T2S IPO was the dominance of individual investors. Of the 111,149 subscribers, 110,015 were natural persons — nearly 99 per cent of total participants. They came from 81 different nationalities, reflecting both domestic enthusiasm and growing international interest in Moroccan equities.
Casablanca-Settat region accounted for nearly 54,000 subscribers, followed by Rabat-Salé with about 18,000 and Fès-Meknès with 10,900.
Younès Benjelloun, chief executive of CFG Bank, which acted as financial adviser and global coordinator for the transaction, said the number of retail participants would rank the T2S IPO among the three largest in recent Moroccan market history by subscriber count, after SGTM and Maroc Telecom.
By contrast, institutional investors — just 1,134 subscribers — concentrated nearly 60 per cent of the shares requested by value.
Cash Plus’s December 2025 listing set a new benchmark for North African fintechs. The company, which operates a hybrid “phygital” model with 5,000 physical branches and a digital Super App serving 2 million users, was valued at $550m upon listing.
The $82.5m IPO was structured as a mix of growth capital and shareholder liquidity, marking a partial exit for private equity firm Mediterrania Capital Partners, while the founding Amar and Tazi families retained their full share count and committed to a seven-year lock-up period.
The offering attracted 80,759 subscribers — of whom 50 per cent were first-time stock market investors — and generated demand for 244.1 million shares against just 3.8 million allocated, with total subscriptions reaching 48.8 billion dirhams ($5.2bn). Seventeen per cent of subscribers were foreign, coming from the UK, US, France, Germany and Senegal.
Cash Plus began trading on December 8, 2025 under the ticker CAP, ranking 34th out of 79 listed companies by market capitalisation. The company has promised to distribute 85 per cent of net profits as dividends annually between 2026 and 2030, positioning itself as a yield play in a market traditionally dominated by cyclical and commodity-linked stocks.
The two tech IPOs reflect broader structural changes in Morocco’s capital markets. After a years-long drought in primary market activity, 2025 saw a notable comeback with three IPOs — Vicenne in July, Cash Plus in November and construction group SGTM. T2S has now extended that momentum into 2026.
The Casablanca Stock Exchange’s ability to attract two high-profile technology IPOs within a year — from sectors as diverse as fintech and medical technology — signals a maturing of Morocco’s equity market. For investors, the question is whether the pipeline of large private companies seeking public capital can be sustained.
T2S began trading on Monday with a theoretical opening price of 301.05 dirhams, well above the reference price of 223 dirhams. Early trading suggested strong demand, though market participants will be watching closely for signs of post-IPO price stabilisation.
For now, however, the message from Casablanca is clear: after years in the doldrums, Morocco’s stock market is back — and technology companies are leading the charge.